Headache at the chronic stage of cerebral venous thrombosis

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
CEPHALALGIA, v.42, n.14, p.1476-1486, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Headache is the most frequent symptom of cerebral venous thrombosis (CVT) but there is limited information about the frequency and phenotype of headache, weeks to months after cerebral venous thrombosis (post-cerebral venous thrombosis headache, post cerebral venous thrombosis headache). Objective To assess the frequency, characteristics and predictors of PCH. Methods In this cross-sectional study, the frequency and characteristics of PCH were assessed in cerebral venous thrombosis survivors. Patients were interviewed between six months and five years after the cerebral venous thrombosis diagnosis. Clinical and imaging characteristics at the time of cerebral venous thrombosis diagnosis, as well as history of headache prior to cerebral venous thrombosis were compared in subjects with (Group(PCH)) and without PCH (Group(control)). Results Subjects (n = 100; 82% women) were assessed, on average, at 1.1 +/- 1.6 years of follow-up. PCH was present in 59% of the patients, phenotypes of tension-type-like headache were present in 31/59 (52.6%) and of migraine-like headache in 16/59 (27.1%). History of primary headache prior to cerebral venous thrombosis was significantly more common (OR: 6.4; 95% CI: 1.7-36.3) in Group(PCH) (33.9%) than in Group(control) (7.3%). Conclusion Post cerebral venous thrombosis headache was present in more than half of the patients. History of prior headache may be a risk factor for post cerebral venous thrombosis headache. Prospective studies are required to confirm these findings and determine mechanisms, as well as interventions for prevention and treatment of post cerebral venous thrombosis headache.
Palavras-chave
Intracranial thrombosis, headache disorders, primary, headache disorders, secondary, migraine disorders, tension-type headache, vascular headaches
Referências
  1. Bendtsen L, 2012, J HEADACHE PAIN, V13, pS1, DOI 10.1007/s10194-011-0402-9
  2. Bernhardt J, 2017, INT J STROKE, V12, P444, DOI 10.1177/1747493017711816
  3. Bonavita V, 2018, NEUROL SCI, V39, pS3, DOI 10.1007/s10072-018-3335-0
  4. Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7
  5. Canhao PC, 2005, STROKE, V36, P1720, DOI 10.1161/01.STR.0000173152.84438.1c
  6. Carod-Artal FJ, 2008, STROKE, V39, P2477, DOI 10.1161/STROKEAHA.107.513671
  7. Dias MC, 2020, HEADACHE, V60, P607, DOI 10.1111/head.13761
  8. Cincura C, 2009, CEREBROVASC DIS, V27, P119, DOI 10.1159/000177918
  9. Crippa J.A.S., 2016, TEMAS PSICOLOGIA, V24, P367, DOI [DOI 10.9788/TP2016.1-25, 10.9788/TP2016]
  10. de Caneda MAG, 2006, ARQ NEURO-PSIQUIAT, V64, P690, DOI 10.1590/S0004-282X2006000400034
  11. Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26
  12. Ferro JM, 2002, CEREBROVASC DIS, V13, P272, DOI 10.1159/000057855
  13. Ferro JM, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0523-2
  14. Field TS, 2019, STROKE, V50, P1598, DOI 10.1161/STROKEAHA.119.025334
  15. Frishberg BM., 2000, US HEADACHE CONSORTI, V1, P8
  16. Girot M, 2007, STROKE, V38, P337, DOI 10.1161/01.STR.0000254579.16319.35
  17. Harriott AM, 2020, NEUROLOGY, V94, pE75, DOI 10.1212/WNL.0000000000008591
  18. Hiltunen S, 2016, J NEUROL, V263, P477, DOI 10.1007/s00415-015-7996-9
  19. IHS, 2004, INT CLASSIFICATION H, P24
  20. Kennis K, 2013, BRIT J GEN PRACT, V63, P443, DOI 10.3399/bjgp13X670895
  21. Koopman K, 2009, J STROKE CEREBROVASC, V18, P198, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.004
  22. Kroenke K, 2012, CAN MED ASSOC J, V184, P281, DOI 10.1503/cmaj.112004
  23. Lebedeva ER, 2021, EUR J NEUROL, V28, P852, DOI 10.1111/ene.14684
  24. Lee S, 2018, KOREAN J ANESTHESIOL, V71, P353, DOI 10.4097/kja.d.18.00242
  25. Mitsikostas DD, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0596-y
  26. Moriarty O, 2014, CURR OPIN SUPPORT PA, V8, P130, DOI 10.1097/SPC.0000000000000054
  27. Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002
  28. Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202
  29. Osorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216, DOI 10.1111/j.1744-6163.2009.00224.x
  30. Queiroz LP, 2006, CEPHALALGIA, V26, P122, DOI 10.1111/j.1468-2982.2005.00998.x
  31. Rizk JG, 2021, JAMA CARDIOL, V6, P1451, DOI 10.1001/jamacardio.2021.3444
  32. Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010
  33. Do TP, 2019, NEUROLOGY, V92, P134, DOI 10.1212/WNL.0000000000006697
  34. Vasconcelos Luciano Góis, 2007, Dement. neuropsychol., V1, P18, DOI 10.1590/S1980-57642008DN10100004